Trial Profile
Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2024
Price :
$35
*
At a glance
- Drugs Guanfacine (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 14 Mar 2024 Planned End Date changed from 28 Feb 2026 to 28 Feb 2025.
- 04 Jan 2021 Planned number of patients changed from 32 to 160.
- 14 Aug 2020 Planned End Date changed from 31 Aug 2021 to 28 Feb 2026.